MYC and gastric cancer: Mechanistically, lobetyolin exerts its antineoplastic effects by enhancing the protein expression of p‐c‐Myc at Thr 58, decreasing the protein expression of p‐AKT at Ser 473 and p‐GSK 3 β at Ser 9, and modulating the AKT/GSK 3 β/c‐Myc signaling pathway to reduce the expression of ASCT 2 in GC cells [133].